Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
This report summarizes evidence considered for these recommendations and provides clinical guidance for the use of MenACWY-TT/MenB-FHbp.PMID:38635488 | PMC:PMC11037438 | DOI:10.15585/mmwr.mm7315a4
Source: MMWR Morb Mortal Wkl... - Category: Epidemiology Authors: Jennifer P Collins Samuel J Crowe Ismael R Ortega-Sanchez Lynn Bahta Doug Campos-Outcalt Jamie Loehr Rebecca L Morgan Katherine A Poehling Lucy A McNamara Source Type: research
More News: Epidemiology | Food and Drug Administration (FDA) | Men | Meningitis | Meningitis Vaccine | Pfizer | USA Health | Vaccines